ARTICLE | Clinical News
Meloxicam: Phase III data
August 8, 2016 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase III trial in 201 patients with acute postoperative pain following a bunionectomy showed that once-daily 30 mg IV meloxicam for up to 3 doses met the prima...